Live Cell Encapsulation Market Size, Growth and Trends Analysis By Manufacturing Technique (Simple Dripping, Electrostatic Dripping, & Others), Polymer Type (Alginate, HEMA-MMA, Chitosan, PAN-PVC, & Others), Application (Drug Delivery & Others)-Forecast till 2027
Market Highlights
It is estimated that the Global Live Cell Encapsulation Market is expected to register a CAGR ~ 3.22% during the forecast period of 2018 to 2023, with an estimated market value of USD 249.87 million in 2017.
Numerous factors such as a high level of research activities in live cell encapsulation technologies and the rising awareness programs in various countries are anticipated to fuel the growth of the market. Moreover, the increasing investments by various public and private organizations have created a lucrative option for many companies to invest in providing new encapsulation techniques, leading to the overall growth of the market. Furthermore, the inclination towards novel drug delivery systems for disease management fuels the growth of the market during the forecast period.
However, the lack of skilled technicians, and ethical and legal issues, and unaffordability of various small-scale companies to enter the market due to high product manufacturing costs are expected to curb the growth of live cell encapsulation market. Moreover, the availability of high-quality raw material is also restraining the growth of the market.
The global live cell encapsulation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in August 2018, Balchem Italia S.r.l., a wholly owned subsidiary of Balchem Corporation, acquired Bioscreen Technologies, S.r.l., a privately held manufacturer of encapsulated and fermented feed nutrition ingredients. With this, the company aims to expand its position in the market.
Regional Analysis
The market in the Americas is expected to dominate the global live cell encapsulation market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region. Europe is expected to hold the second largest position in the global live cell encapsulation market. The market growth in this region is because of the presence of a well-established healthcare system and increase in life-threatening diseases. For instance, according to cancer research UK, there were approximately 9,921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for the use of new techniques such as encapsulation as well as an increase in the market demand for cellular research. These factors are expected to have a positive impact on the live cell encapsulation market. Asia-Pacific is estimated to be the fastest growing region in the market due to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. The market in the Middle East & Africa is likely to account for the smallest share of the global live cell encapsulation market. The market growth in this region owes to the low disposable income in the region.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7772
Segmentation
The Global Live Cell Encapsulation Market has been segmented into manufacturing technique, polymer type, and application. The market, based on manufacturing technique, has been segmented into simple dripping, electrostatic dripping, coaxial airflow, rotating disk atomization, and others. The market, by polymer type, has been further segmented into alginate, HEMA-MMA, Chitosan, silica, cellulose sulfate, PAN-PVC, and others. The market, by application, has been segmented into drug delivery, regenerative medicine, cell transplantation, and others.
Key Players
Some of the key players in the global live cell encapsulation market are Evonik Industries, Balchem Corporation, Biotime, Inc., Blacktrace Holdings Ltd., Sigilon Therapeutics, Inc., BÜCHI Labortechnik AG, Encapsys, LLC, Lycored, MiKroCaps, Living Cell Technologies, Merck KGaA, Reed Pacific Pty Limited, Neurotech Holdings, LLC, Sernova Corporation, and Viacyte, Inc.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/live-cell-encapsulation-market-7772
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Related Report:
- Live Cell Encapsulation Market Research Report - Global Forecast till 2025
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
February 18, 2019: The global live cell imaging market is projected to grow at a significant CAGR during the forecast period.
Live cell imaging is gaining a wider audience since it is used as a popular tool for biological mechanisms and contributes significantly to the functions of multiple cellular processes.
Subsequently, the market growth is also backed by rise in prevalence of chronic disorders and demand for diagnostic facilities.
Use of imaging for cell biologists helps them understand the fundamental nature of cell structure and function.Application segment for live cell imaging market includes developmental biology, stem cell & drug discovery, drug genetics, immunology, microbiology and neurobiology.
According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques.The report “Live Cell Imaging Market Outlook 2022” is available now at Live Cell Imaging Market Size, Live Cell Imaging Market Share, Live Cell Imaging Industry Trendshttps://www.radiantinsights.com/research/live-cell-imaging-market-outlook-2022Asia-Pacific regions are likely to grow at a higher rate due to availability of patient pool and prevalence of chronic diseases.
The live cell imaging market is expected to reach US$ 7 Billion by 2022.Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World.
Australian Investment Education provide Investment Education and Strategies for Options Trading, Stocks, Share Market, Forex and ETFs.
Course are offered live and online.We are not in business with our clients, we are in partnership.
Check out our market leading services and discover how we can help you enjoy a richer financial future.
The Live Vaccines Market Research Report Forecast is a valuable source of insightful data for business strategists.
It provides the industry overview with recent trends, size, share, growth analysis, historical, futuristic data, revenue, demand and strategic development.The entire live vaccines market has been sub-categorized into type, route of administration, application, and patient.
The report provides an analysis of these subsets with respect to the geographical segmentation.
This research study will keep marketer informed and helps to identify the target demographics for a product or service.Request a FREE Sample Copy of Global Live Vaccines Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/live-vaccines-market/download-sampleBy TypeViralBacterialBy Route of AdministrationOralInjectionIntra-NasalCombination of injection PatchInhalationBy ApplicationMeaslesMumpsRubellaVaricellaYellow FeverRotavirusBCGVacciniaInfluenzaTyphoidOral PolioSmallpoxChickenpoxOthersBy PatientAdultsPediatricThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the live vaccinesmarket include Merck & Co., GlaxoSmithKline plc, Pfizer Inc., Astellas Pharma Inc., Emergent BioSolutions, AstraZeneca plc, Serum Institute of India Pvt.
Ltd., Bharat Biotech, Sun Pharmaceutical Industries Limited, and Cipla Limited.
